Summary: Researchers achieved the first direct molecular mapping of how deep brain stimulation (DBS) affects human cortical tissue by applying DBS-like electrical patterns to living human temporal cortex slices maintained ex vivo.
Using donated neurosurgical brain tissue kept alive in the laboratory for several days, the team applied stimulation patterns similar to clinical DBS and combined electrophysiological recording with single-nucleus sequencing. The results show that electrical stimulation synchronizes neuronal firing — a core signature of memory formation and synaptic plasticity — and triggers distinct, cell-type-specific genetic programs in neurons and supporting glial cells.
Key Facts
- First in vitro DBS model on living human slices: This work presents the first successful demonstration of DBS-like electrical protocols on intact, functional human brain tissue maintained outside the body.
- Induction of neural synchronization: Electrical stimulation directly increased coordinated firing across temporal cortex networks, linking electrophysiological changes to processes involved in memory encoding and plasticity.
- Cell-type-specific transcriptomic shifts: Single-nucleus RNA profiling revealed that neurons and non-neuronal cells — notably astrocytes — activate distinct genetic programs in response to electrical fields.
- Validation with in vivo clinical tissue: Gene expression signatures observed in ex vivo stimulated slices were also identified in cortical tissue taken from patients who received clinical DBS before surgical resection.
- Strategies for memory preservation: Mapping molecular responses at single-cell resolution provides candidate targets for combining DBS hardware with targeted neuropharmacology to support cognitive resilience.
Source: UCLA
Neurons that once encoded an individual’s memories are now helping scientists identify genetic targets that could inform future interventions to preserve memory and slow cognitive decline.
Published in the journal Nature, the study by researchers at UCLA Health and University of Texas Southwestern Medical Center used fresh human temporal cortex tissue donated by patients undergoing neurosurgery. These intact cortical slices were kept viable in specialized culture chambers for several days, allowing investigators to deliver precise electrical stimulation while recording network activity and profiling gene expression from individual cell nuclei.
Deep brain stimulation delivers targeted electrical pulses via implanted electrodes and has established clinical benefits for movement and psychiatric disorders such as Parkinson’s disease and obsessive-compulsive disorder. More recently, researchers have investigated whether neuromodulation can help counter cognitive decline, but the cellular and molecular responses in human brain tissue have remained largely untested outside of animal or cell culture systems. This study bridges that gap by directly applying DBS-like patterns to living human cortical tissue obtained from surgical resections.
Electrophysiological recordings showed that stimulation increased synchronization of action potential firing across neuronal populations in the temporal cortex — a pattern associated with improved information encoding and synaptic strengthening. In parallel, single-nucleus transcriptomics revealed that different cell types engage separate gene regulatory programs: excitatory and inhibitory neurons expressed distinct immediate early genes and plasticity-related pathways, while astrocytes and other glial cells initiated transcriptional responses linked to metabolic support, neurotransmitter regulation, and synaptic maintenance.
Importantly, researchers validated these ex vivo molecular signatures by comparing them with cortical tissue removed from patients who had received clinical stimulation before surgery. The overlap supports the translational relevance of the ex vivo platform to human neuromodulation and demonstrates that the observed transcriptomic shifts are not artifacts of the laboratory environment but reflect responses occurring in vivo.
“Working with donated, living human brain tissue presented both technical challenges and profound opportunity,” said senior author Genevieve Konopka, chair of the Department of Neurobiology at UCLA Health. “By identifying which genes are activated in specific cell types during stimulation, we can begin designing DBS strategies that intentionally recruit beneficial molecular programs and combine electrical therapy with targeted drugs to enhance cognitive outcomes.”
The tissue samples came from the temporal cortex, a region critically involved in memory and higher cognitive functions. The authors note limitations and future directions: longer-term stimulation effects remain to be explored, interactions between stimulated cells and their neighbors need clarification, and deeper brain regions — primary clinical DBS targets — are harder to obtain from living donors and require further study.
Key Questions Answered:
Q: How did researchers apply deep brain stimulation to living human brain tissue outside the body?
A: Fresh temporal cortex tissue was obtained from neurosurgical resections. Researchers maintained intact slices in specialized culture chambers that preserved cellular viability and circuit function for several days, enabling precise electrical stimulation and simultaneous electrophysiological recording.
Q: Why is astrocyte activation during deep brain stimulation significant?
A: Astrocytes are crucial support cells that regulate metabolic balance, neurotransmitter uptake, and synaptic plasticity. Their distinct transcriptional response to stimulation indicates that DBS engages broader glial–neuronal networks, not just neuronal firing, which may be essential for durable therapeutic effects on memory and brain health.
Q: How can these molecular findings improve clinical treatments for cognitive decline?
A: Identifying genes that are switched on in specific cell types during stimulation allows clinicians and researchers to refine DBS settings to favor beneficial molecular programs. Those genes also represent potential drug targets for combination therapies, where neuropharmacology augments the effects of electrical neuromodulation to better preserve or restore cognitive function.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full by the editorial team.
- Additional context and clarifications were added by staff to improve accessibility.
About this genetics and neuroscience research news
Author: Will Houston
Source: UCLA
Contact: Will Houston – UCLA
Image: Image credit: Neuroscience News
Original Research: Open access. “Stimulation modulates gene-linked cell assemblies in the human brain” by Haley Moore, Mantre Dehnad, Anne Freelin, Bryan Granger, Suganya Subramanian, Tjitse van der Molen, Ashwinikumar Kulkarni, Stefano Berto, Bradley C. Lega & Genevieve Konopka. Nature. DOI: 10.1038/s41380-026-03749-3
Abstract
Stimulation modulates gene-linked cell assemblies in the human brain
Reshaping cortical circuits through stimulation is an emerging therapeutic approach for restoring cognitive function, yet the underlying biological mechanisms in humans remain largely unexplored. The authors developed an ex vivo platform that integrates microelectrode array stimulation with simultaneous recording and single-nucleus genomics from resected temporal cortex obtained during neurosurgery. They report that stimulation strengthens cell assemblies and link this effect to cell-type-specific gene regulatory networks. They further demonstrate generalizability by identifying common cell-specific gene expression signatures after in vivo stimulation. Together, these results provide a foundation for identifying physiologically linked, targetable genetic signatures that could be harnessed for therapeutic benefit through neuromodulation strategies.